You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 9,579,324

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,579,324 protect, and when does it expire?

Patent 9,579,324 protects VORANIGO and is included in one NDA.

This patent has sixty-five patent family members in thirty-five countries.

Summary for Patent: 9,579,324

Title:	Therapeutically active compounds and their methods of use
Abstract:	Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
Inventor(s):	Konteatis Zenon D., Popovici-Muller Janeta, Travins Jeremy M., Zahler Robert, Cai Zhenwei, Zhou Ding
Assignee:	AGIOS PHARMACEUTICALS, INC
Application Number:	US14328885
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 9,579,324

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Servier	VORANIGO	vorasidenib	TABLET;ORAL	218784-001	Aug 6, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
Servier	VORANIGO	vorasidenib	TABLET;ORAL	218784-002	Aug 6, 2024		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up		Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,579,324

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	096902	⤷ Sign Up
Australia	2014289744	⤷ Sign Up
Australia	2019201179	⤷ Sign Up
Brazil	112016000561	⤷ Sign Up
Brazil	122017014843	⤷ Sign Up
Canada	2917358	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.